E. Premkumar Reddy

Directeur/Membre du Conseil chez Translational Development Acquisition Corp.

Profil

E.
Premkumar Reddy is the founder of Onconova Therapeutics, Inc., which was founded in 1998.
He held the title of Director at Onconova Therapeutics, Inc. from 1999 to 2020.
Currently, Dr. Premkumar Reddy holds the position of Professor & Director-Cancer Therapeutics Program at Icahn School of Medicine at Mount Sinai since 2013.
He is also the Director-Experimental Cancer Therapeutics Program at The Tisch Cancer Institute at Mount Sinai since 2010.
Additionally, he is a Director at Translational Development Acquisition Corp.
Previously, Dr. Premkumar Reddy worked as the Director & Professor at Fels Institute of Government from 1992 to 2010.
Dr. Premkumar Reddy completed his undergraduate, graduate, and doctorate degrees at Osmania University.

Postes actifs de E. Premkumar Reddy

Sociétés	Poste	Début
Icahn School of Medicine at Mount Sinai	Corporate Officer/Principal	01/03/2010
The Tisch Cancer Institute at Mount Sinai	Corporate Officer/Principal	01/03/2010
Translational Development Acquisition Corp.	Directeur/Membre du Conseil	-

Anciens postes connus de E. Premkumar Reddy

Sociétés	Poste	Fin
TRAWS PHARMA, INC.	Fondateur	27/08/2020
Fels Institute of Government	Directeur/Membre du Conseil	01/02/2010

Formation de E. Premkumar Reddy

Osmania University

Doctorate Degree